Top Markets
Coin of the day
PharmAust Limited PharmAust Limited

PharmAust Limited

PAA
주식 순위 #26700
Operating internationally, including in Switzerland, Australia, Sweden, and the... Operating internationally, including in Switzerland, Australia, Sweden, and the United States, PharmAust Limited specializes in developing targeted cancer treatments for both human and animal applications. The company also cultivates intellectual property in drug discovery, addressing a range of cancers and neurological conditions. Its primary therapeutic candidate is Monepantel (MPL), a small molecule compound currently undergoing Phase II clinical trials for cancer treatment. Beyond its drug development pipeline, PharmAust provides synthetic and medicinal chemistry products and expert services to the global drug discovery and pharmaceutical sectors. The firm also holds a research agreement with the Walter and Eliza Hall Institute, investigating in vitro the effects of MPL on human T-lymphotrophic virus-1 (HTLV-1) infections. Established in 2000, PharmAust Limited is headquartered in Bentley, Australia.
주가
$0.12164306
마지막 동기화: 2024-11-11
시가총액
$38.53M
변동 (1일)
-4.14%
변동 (1년)
0.00%
국가
AU
거래 PharmAust Limited (PAA)

카테고리

PharmAust Limited (PAA)의 수익
Jun 2024 기준 수익 TTM: $-6.31M
PharmAust Limited의 최신 재무 보고서에 따르면 회사의 현재 수익은 $-6.31M입니다. 2023년에 회사는 $-4.14M의 수익을 올렸으며 이는 2022년의 수익 $-1.18M과 감소입니다. 이 페이지에 표시된 수익은 이자 및 세금 공제 전 수익으로, 즉 EBIT입니다.
PharmAust Limited의 수익 기록 (2001 ~ 2026)
연말 수익
연도 수익 변화
2026 (TTM) $-6.31M 0.00%
2024 $-6.31M 52.51%
2023 $-4.14M 251.26%
2022 $-1.18M 17.50%
2021 $-1.00M 6.70%
2020 $-939.77K -13.74%
2019 $-1.09M -41.67%
2018 $-1.87M 80.51%
2017 $-1.03M -64.63%
2016 $-2.93M 97.39%
2015 $-1.48M 19.24%
2014 $-1.24M 112.82%
2013 $-584.08K -86.59%
2012 $-4.35M -29.96%
2011 $-6.22M 1,573.65%
2010 $-371.45K 155.62%
2009 $-145.32K -97.37%
2008 $-5.53M -0.89%
2007 $-5.58M 173.13%
2006 $-2.04M -20.13%
2005 $-2.56M 42.56%
2004 $-1.80M 29.13%
2003 $-1.39M -33.40%
2002 $-2.09M 96.03%
2001 $-1.06M 0.00%
유사 기업 또는 경쟁사의 수익
회사 수익 수익 차이 국가
$5.27B -83,669.91%
US
$1.95B -31,004.03%
NL
$1.61B -25,675.00%
AU
$-3.09B 48,807.15%
US
- -
CH